At the end of September, I reported on a "new" drug from Actos maker Takeda pharmaceutical, which is currently marketed outside the U.S. as Nesina. It is not actually new; it is a combination of Actos and another anti-diabetic drug, alogliptin. which was submitted to the FDA for approval in late 2007, but withdrawn the following year after the FDA determined that additional data was needed.
Hip implant surgery is supposed to relieve pain. In too many cases however, it has the opposite effect – and not simply because they wear out.
The health complications associated with metal-on-metal hip implants is well known and thoroughly documented. What is less well known is the risk of damage to the sciatic nerve, which can leave a patient in excruciating and often untreatable pain.
In September 2011, Chief Judge Garrett Brown of the United States District Court for the District of New Jersey announced his upcoming retirement from the federal bench. Chief Judge Brown was the judge assigned by the Judicial Panel on Multidistrict Litigation ("JPML") to oversee the Fosamax Femur MDL pending in the District of New Jersey. As a result of Judge Brown's announced retirement, the JPML reassigned the Fosamax Femur MDL to District Judge Joel Pisano, effective November 22, 2011. Like Chief Judge Brown, Judge Pisano sits in Trenton, NJ. (
"Corporations are people, my friend." - GOP presidential candidate Mitt Romney
We must give Mr. Romney credit for so openly declaring what most 99% of Americans have long suspected and what the inexcusable Citizens United v. FEC decision made abundantly clear. The question that so many of us have however is that if corporations are people with human rights of free speech, how come they can't be put in jail like natural humans? How come they don't face criminal charges like human felons when they steal and commit murder?
If you are one of the 37,000+ people who have received defective DePuy hip implants and are thinking about joining the rapidly-growing ranks of plaintiffs against this corporation, don't think about it too much longer. Your window of opportunity may be closing soon.
Considering the nightmare stories about anti-diabetic drugs such as Actos and Avandia and the potentially fatal side effects they cause, one wonders if there are any alternatives.
After the Type 2 diabetic drug Actos was linked to an increased risk of bladder cancer last summer, it was pulled off the shelves in France and Germany. (Of course, it remains available in the US, where the large pharmaceutical corporations have bought and paid for legislators and essentially control the FDA – but the agency has at least required a warning label.)
Those who have been worried about the health consequences of metal-on-metal total hip replacements may have an alternative in the form of hip resurfacing, a technique that has been available since 2006. However, evidence shows that while the technique has several advantages over total hip replacement, it results in the same problems.
In its insatiable quest to maximize its profits – even if people have to sicken and die – it seems there is no limit to how far Big Pharma will go.
A study of over 3000 women with polycystic ovary syndrome found an increased risk of adverse pregnancy outcomes such as gestational diabetes, c-section birth, and other issues.
On Friday, October 28, 2011 the Coast Guard Cutter Cypress, which is homeported in Pensacola, Florida, offloaded 7 tons of cocaine at the Coast Guard base in St. Petersburg, Florida. The street value of the cocaine was worth roughly $180 million dollars which is about a third of what law enforcement pulls off the streets in a year in the entire United States. The cocaine came from a single, self-propelled semisubmersible vessel which had been detected and stopped by another Coast Guard Cutter off the coast of Honduras on September 30, 2011.
Since the first lawsuit involving the type-2 diabetic drug Actos was filed near the end of July 2011, 53 additional plaintiffs across the country have come forward – and this may be just the beginning.
Endorsements from celebrities and prominent athletes have always given a big boost to product sales. It's also very lucrative for the endorser, particularly when they are past their prime. Penny Brown, a 51-year-old former gymnast from the U.K., was a paid spokesperson for DePuy's ASR hip plants several years after she received the device herself.
Now, she's having a few regrets as she joins the ranks of those who are suffering the effects brought on by the deterioration of her implant.
Let me preface this with a disclaimer: I am not offering any medical advice here. The information presented here is strictly informational; should the reader be interested in utilizing some of the care options presented, s/he is strongly advised to discuss them with his/her primary care physician or other medical professional (preferably one who is not on the payroll of, or taking money from one of the big pharmaceutical corporations).
Studies question whether the use of anti-inflammatory drugs increase the risk of miscarriages or birth defects.
The fact that metal-on-metal hip implants such as those manufactured by DePuy and Zimmer are bad news. As these devices wear over time, microscopic bits of toxic metal make their way into the bloodstream, leading to a host of serious ailments.
In its mad rush to maximize profits, Big Pharma will go to great lengths to rush their products to market – then dupe low-information Americans into believing that these products are the only alternative they have for what ails them. They will say this even when low-risk, low-cost alternative treatments such as diet, exercise and lifestyle changes are effective (have you noticed how pharmaceutical ads in recent years often warn patients that "it may not be enough"?)
800.277.1193
Phone